Clinical trials
Liposarcoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 2 |
| Fudan University | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| HRYZ Biotech Co. | 1 |
| Pfizer | 1 |
| Xian-Janssen Pharmaceutical Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma | 9 |
| Sarcoma | 4 |
| Leiomyosarcoma | 3 |
| Desmoplastic Small Round Cell Tumor | 2 |
| Fibrosarcoma | 2 |
| Hemangiosarcoma | 2 |
| Neurofibrosarcoma | 2 |
| Adenocarcinoma of Lung | 1 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.